Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease (Q73107122)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

W A Stack

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S D Mann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A J Roy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

P Heath

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Sopwith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Freeman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Holmes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Long

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M A Kamm

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

349

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

9051

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

521-524

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

Low-Dose Cyclosporine for the Treatment of Crohn's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

CD4 antibody treatment in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

European trial of cyclosporine in chronic active Crohn's disease: a 12-month study. The European Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

Tumour-necrosis-factor antibody treatment in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

A simple index of Crohn's-disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2980083-9

7 January 2021

10.1016/S0140-6736(97)80083-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9048788%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference